Rigel Pharmaceuticals Inc (RIGL) reports a 68% increase in net product sales and outlines promising developments for 2025.

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and ...

Rigel Pharmaceuticals reports strong Q1 2025 growth, with revenue up 68% YoY. Learn about their $200M+ guidance, robust pipeline, and market strategy.

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported first-quarter profit of $11.4 million. The South San Francisco, ...

A 10-week-old puppy is safe and on the road to recovery after being found abandoned in a crate along a Lamar County road ...

Local elected officials have adapted to today’s tech-dominated media landscape by crafting online personas and digitally ...